Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
US Stock MarketDetailed Quotes
ORBT ORBIT INTERNATIONAL INC
- 4.300
- +0.150+3.61%
15min DelayClose Jan 8 16:00 ET
14.40MMarket Cap4.48P/E (TTM)
4.350High4.250Low6.10KVolume4.350Open4.150Pre Close26.51KTurnover0.34%Turnover Ratio23.89P/E (Static)3.35MShares6.30852wk High0.77P/B7.70MFloat Cap4.06052wk Low--Dividend TTM1.79MShs Float8.127Historical High--Div YieldTTM2.41%Amplitude3.478Historical Low4.345Avg Price1Lot Size
ORBIT INTERNATIONAL INC Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | (Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | (Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | (Q3)Sep 30, 2015 | (Q2)Jun 30, 2015 | (Q1)Mar 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 917.84%2.45M | -34.47%1.05M | 513.67%1.15M | -190.03%-316K | 139.33%566K | -3.60%241K | 684.36%1.61M | -761.90%-278K | -73.77%351K | -68.30%-1.44M |
| Net income from continuing operations | 54.32%1.39M | 42.02%828K | 44.90%455K | -77.64%74K | 110.74%35K | 145.08%902K | 189.28%583K | 373.04%314K | 293.57%331K | 69.30%-326K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 130.00%3K | --0 | 150.00%1K | -90.91%1K | 133.33%1K |
| Depreciation and amortization | -32.23%185K | -39.13%42K | -31.34%46K | -27.54%50K | -30.88%47K | -37.95%273K | 1.47%69K | 4.69%67K | 11.29%69K | -72.36%68K |
| Deferred tax | ---300K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non cash items | 0.00%-5K | 50.00%-1K | ---- | ---- | 0.00%-1K | ---5K | ---2K | ---1K | ---1K | ---1K |
| Change In working capital | 214.18%1.13M | -50.05%471K | 194.50%636K | -615.87%-451K | 139.45%471K | -156.99%-987K | 201.28%943K | -1,075.36%-673K | -104.47%-63K | -1,890.00%-1.19M |
| -Change in receivables | 134.78%480K | 11.50%349K | 141.46%255K | -1,311.43%-494K | 135.47%370K | -226.84%-1.38M | -34.38%313K | -2,021.88%-615K | -104.05%-35K | -264.69%-1.04M |
| -Change in inventory | 75.19%692K | -24.24%450K | 7.52%486K | 89.97%-31K | 37.72%-213K | -44.68%395K | 2,682.61%594K | 270.49%452K | -151.93%-309K | -1,810.00%-342K |
| -Change in payables and accrued expense | -67.80%19K | -321.31%-135K | 110.66%37K | -77.54%42K | -52.53%75K | 120.85%59K | 135.06%61K | -863.89%-347K | 2,177.78%187K | 346.88%158K |
| -Change in other current assets | 238.46%54K | 380.00%48K | 14.85%-86K | -142.50%-17K | 808.33%109K | -188.64%-39K | -75.61%10K | -134.88%-101K | -11.11%40K | 1,100.00%12K |
| -Change in other current liabilities | -10,100.00%-102K | ---- | ---- | ---- | 407.41%137K | -100.58%-1K | ---- | ---- | 553.85%59K | 485.71%27K |
| -Change in other working capital | 23.81%-16K | -308.82%-139K | -333.33%-56K | 3,820.00%186K | -16.67%-7K | -425.00%-21K | 20.93%-34K | 114.63%24K | 93.15%-5K | -102.17%-6K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 917.84%2.45M | -34.47%1.05M | 513.67%1.15M | -190.03%-316K | 139.33%566K | -3.60%241K | 684.36%1.61M | -761.90%-278K | -73.77%351K | -68.30%-1.44M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 77.78%-4K | -2,200.00%-23K | -850.00%-15K | -100.00%-16K | 554.55%50K | 86.96%-18K | 80.00%-1K | 102.99%2K | 82.22%-8K | 47.62%-11K |
| Net PPE purchase and sale | -17.50%-47K | -225.00%-26K | 37.50%-5K | -60.00%-16K | --0 | 60.78%-40K | -100.00%-8K | 73.33%-8K | 72.22%-10K | 56.25%-14K |
| Net investment purchase and sale | 95.45%43K | -57.14%3K | -200.00%-10K | --0 | 1,566.67%50K | 161.11%22K | 800.00%7K | 127.03%10K | 122.22%2K | -72.73%3K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 77.78%-4K | -2,200.00%-23K | -850.00%-15K | -100.00%-16K | 554.55%50K | 86.96%-18K | 80.00%-1K | 102.99%2K | 82.22%-8K | 47.62%-11K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -244.72%-2.12M | -1,044.63%-1.39M | 15.92%-280K | -193.02%-252K | -170.67%-203K | -14.95%-615K | 15.38%-121K | -291.76%-333K | -1.18%-86K | 66.22%-75K |
| Net issuance payments of debt | -347.62%-1.41M | -1,105.88%-1.03M | -93.75%-155K | -33.33%-100K | -73.33%-130K | 16.00%-315K | -13.33%-85K | 5.88%-80K | 11.76%-75K | 42.31%-75K |
| Net common stock issuance | -136.67%-710K | -900.00%-360K | 50.59%-125K | -1,281.82%-152K | ---73K | -87.50%-300K | 47.06%-36K | ---253K | ---11K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -244.72%-2.12M | -1,044.63%-1.39M | 15.92%-280K | -193.02%-252K | -170.67%-203K | -14.95%-615K | 15.38%-121K | -291.76%-333K | -1.18%-86K | 66.22%-75K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.33%1.75M | 827.86%2.43M | 80.94%1.58M | 251.79%2.16M | -18.33%1.75M | -16.51%2.14M | -89.77%262K | -67.40%871K | -58.06%614K | -16.51%2.14M |
| Current changes in cash | 183.93%329K | -123.91%-355K | 240.39%855K | -327.24%-584K | 127.08%413K | 7.33%-392K | --1.49M | ---609K | -78.73%257K | -38.89%-1.53M |
| End cash Position | 18.83%2.08M | 18.83%2.08M | 827.86%2.43M | 80.94%1.58M | 251.79%2.16M | -18.33%1.75M | -18.33%1.75M | -89.77%262K | -67.40%871K | -58.06%614K |
| Free cash flow | 1,097.01%2.41M | -35.77%1.03M | 500.35%1.15M | -197.36%-332K | 138.95%566K | 52.27%201K | 642.03%1.6M | -2,483.33%-286K | -73.81%341K | -63.81%-1.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |